Accessibility Menu
Biomind Labs logo

Biomind Labs

(OTC) BMNDF

Current Price$0.01
Market Cap$861.00K
Since IPO (2021)-96%
5 Year-99%
1 Year-89%
1 Month-91%

Biomind Labs Financials at a Glance

Market Cap

$861.00K

Revenue (TTM)

$0.00

Net Income (TTM)

-$893.84K

EPS (TTM)

-$0.01

P/E Ratio

-0.97

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$0.01

Volume

300

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.13

Estimated Earnings Date

N/A

BMNDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biomind Labs

Industry

Pharmaceuticals

Employees

6

CEO

Alejandro Antalich

Headquarters

Canelones, UY

BMNDF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

60.67%

Return on Capital

N/A

Return on Assets

-1550.24%

Earnings Yield

-1.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$861.00K

Shares Outstanding

77.57M

Volume

300

Avg. Volume

171.081

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$818.05K

EBITDA

-$820.53K

Operating Cash Flow

-$134.20K

Capital Expenditure

$0.32

Free Cash Flow

-$134.20K

Cash & ST Invst.

$36.73K

Total Debt

$691.89K

Biomind Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$861.00K

N/A

Market Cap/Employee

$172.20K

N/A

Employees

5

N/A

Net Income

-$102.66K

-53.8%

EBITDA

-$79.11K

-68.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$36.73K

+263.0%

Total Debt

$691.89K

-21.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$691.89K

-21.7%

Return on Assets

-15.50%

N/A

Return on Invested Capital

52.49%

N/A

Free Cash Flow

-$65.04K

-14363.2%

Operating Cash Flow

-$65.04K

-14363.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CBDYTarget Group Inc.
$0.00+0.00%
EVFMEvofem Biosciences, Inc.
$0.01-9.09%
ISCOInternational Stem Cell Corporation
$0.20+11.11%
MRZMMarizyme, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
INTCIntel
$120.35-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%

Questions About BMNDF

What is the current price of Biomind Labs?

Biomind Labs is trading at $0.01 per share.

What is the 52-week range for Biomind Labs?

Over the past 52 weeks, Biomind Labs has traded between $0.01 and $0.13.

How much debt does Biomind Labs have?

As of the most recent reporting period, Biomind Labs reported total debt of $786.78K.

How much cash does Biomind Labs have on hand?

Biomind Labs reported $14.39K in cash and cash equivalents in its most recent financial results.

What is Biomind Labs’s dividend yield?

Biomind Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.